ADVANCED ENZYME TECHNOLOGIES
Back to Income Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹624 Cr | ₹541 Cr | ₹529 Cr | ₹502 Cr | ₹444 Cr |
What is the latest Revenue of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹624 Cr |
| Mar2024 | ₹541 Cr |
| Mar2023 | ₹529 Cr |
| Mar2022 | ₹502 Cr |
| Mar2021 | ₹444 Cr |
How is Revenue of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹624 Cr | 15.39 | |
| Mar2024 | ₹541 Cr | 2.13 | |
| Mar2023 | ₹529 Cr | 5.49 | |
| Mar2022 | ₹502 Cr | 13.03 | |
| Mar2021 | ₹444 Cr | - | |
Compare Revenue of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,094.6 Cr | -8.6% | -9.3% | -15.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -8.6% |
-9.3% |
-15.8% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses